Mechanisms of selective killing of neuroblastoma cells by natural killer cells and lymphokine activated killer cells. Potential for residual disease eradication (Q41782234)

From Wikidata

Jump to navigation Jump to search

scientific article published on May 1993

Language	Label	Description	Also known as
English	Mechanisms of selective killing of neuroblastoma cells by natural killer cells and lymphokine activated killer cells. Potential for residual disease eradication	scientific article published on May 1993

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

Mechanisms of selective killing of neuroblastoma cells by natural killer cells and lymphokine activated killer cells. Potential for residual disease eradication (English)

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

eradication of infectious diseases

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Malcolm Brenner

5

object named as

M K Brenner

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

E Coustan-Smith

3

object named as

E Coustan-Smith

1 reference

Europe PubMed Central

9 October 2017

PMC publication ID

author name string

N K Foreman

1

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

D R Rill

2

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

E C Douglass

4

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

language of work or name

0 references

publication date

1 May 1993

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

67

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

5

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

933-938

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

Do infants with stage IV-S neuroblastoma need treatment?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968443

6 June 2018

High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968443

6 June 2018

Special pattern of widespread neuroblastoma with a favourable prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968443

6 June 2018

ICAM, an adhesion ligand of LFA-1, is homologous to the neural cell adhesion molecule NCAM.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968443

6 June 2018

Purified lymphocyte function-associated antigen 3 binds to CD2 and mediates T lymphocyte adhesion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968443

6 June 2018

Molecular analysis and clinical significance of N-myc amplification and chromosome 1p monosomy in human neuroblastomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968443

6 June 2018

Cloning of the beta subunit of the leukocyte adhesion proteins: homology to an extracellular matrix receptor defines a novel supergene family

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968443

6 June 2018

A phase I study of interleukin-2 in children with cancer and evaluation of clinical and immunologic status during therapy. A Pediatric Oncology Group Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968443

6 June 2018

The influence of natural killer cells in neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968443

6 June 2018

The CD2-LFA-3 and LFA-1-ICAM pathways: relevance to T-cell recognition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968443

6 June 2018

The prognostic significance of autologous bone marrow transplant in advanced neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968443

6 June 2018

High-dose chemoradiotherapy supported by marrow infusions for advanced neuroblastoma: a Pediatric Oncology Group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968443

6 June 2018

The immunologic detection of minimal residual disease in acute leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968443

6 June 2018

Cytotoxicity of lymphokine-activated killer cells against human neuroblastoma cells: modulation by neuroblast differentiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968443

6 June 2018

Interleukin-2 and lymphokine-activated killer cells in 15 children with advanced metastatic neuroblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968443

6 June 2018

Cell adhesion molecules expression and modulation on human neuroblastoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968443

6 June 2018

Expression of leucocyte adhesion molecules on 66 clinical neuroblastoma specimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968443

6 June 2018

Human neuroblastoma cell lines are susceptible to lysis by natural killer cells but not by cytotoxic T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8494726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular pathways of adhesion in spontaneous rosetting of T-lymphocytes to the Hodgkin's cell line L428

1 reference

https://pubmed.ncbi.nlm.nih.gov/8494726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endogenously generated activated killer cells circulate after autologous and allogeneic marrow transplantation but not after chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8494726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro induction of lymphokine-activated killer (LAK) activity in patients with neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8494726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human melanoma cells with high susceptibility to cell-mediated lysis can be identified on the basis of ICAM-1 phenotype, VLA profile and invasive ability

1 reference

https://pubmed.ncbi.nlm.nih.gov/8494726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro modulation and relationship between N-myc and HLA class I RNA steady-state levels in human neuroblastoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/8494726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Possible mechanism of selective killing of myeloid leukemic blast cells by lymphokine-activated killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/8494726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is more better? Dose intensity in neuroblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8494726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/8494726

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1993.173

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

9 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41782234&oldid=2204767983"